Close
Close
Finance News

Novocure to Present at Two Upcoming Investor Conferences in December

3.0
3.0 from 5 votes
Thursday, November 23, 2017

ST. HELIER, Jersey. - Novocure (NASDAQ:NVCR) announced that it will participate in two upcoming investor conferences in December.

Asaf Danziger, Novocure's Chief Executive Officer, and Wilco Groenhuysen, Novocure's Chief Financial Officer, will participate in a fireside chat at the Nasdaq 37th International Investor Conference on December 5, 2017, in London. Mr. Danziger and Mr. Groenhuysen's presentation will begin at 8:15 a.m. GMT (3:15 a.m. EST) and will be followed by a Q&A session.

A live audio webcast of the presentation can be accessed from the Investor Relations page of Novocure's website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the presentation.

Additionally, William Doyle, Novocure's Executive Chairman, will participate in the Global Mizuho Investor Conference on December 5, 2017, in New York City. Mr. Doyle will participate in one-on-one meetings with investors throughout the day.

All presentation materials can be accessed from the Investor Relations page of Novocure's website, www.novocure.com/investor-relations, and will be available for at least 14 days following the events.

About Novocure

Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure's commercialized product is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.

Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel. For additional information about the company, please visit www.novocure.com or follow us at www.twitter.com/novocure.

Contacts:

Media and Investors
Novocure
Ashley Cordova,
Phone: 212-767-7558
Email: acordova@novocure.com

Source: Novocure
3.0
3.0 from 5 votes
Free Newsletter
Videos